MAGI3 and renal cell carcinoma: Our study revealed that MAGI3 significantly reduces Ang-(1-7)-induced ERK phosphorylation in a dose- and time-dependent manner through its interaction with the MAS receptor, shedding light on the critical role of the MAGI3/MAS/ERK axis in RCC development and progression.